The Fiscal Year 2005 (FY05) Appropriation Bill was signed by President Bush on August 5, 2004. This program announcement is being released prior to the receipt of funds appropriated in the bill for this research program; funding of proposals received in response to this program announcement is contingent on the receipt of funds at the United States Army Medical Research and Materiel Command (USAMRMC).
The United States Army Medical Research and Materiel Command (USAMRMC), Office of the Congressionally Directed Medical Research Programs (CDMRP) invites applications for funding for the FY05 Neurofibromatosis Research Program (NFRP) New Investigator Award Research Award.
The overall goal of the FY05 NFRP is to develop effective therapies for NF1, NF2, and Schwannomatosis. Within this context, support for the training of NF researchers, the encouragement of established scientists in the field, and the attraction of new scientific expertise from other fields are essential to the NF community. Proposals to the NFRP are sought across all areas of laboratory, clinical, behavioral, and epidemiological research including all disciplines within the basic, clinical, psychosocial, behavioral, sociocultural, and environmental sciences; nursing; occupational health; alternative therapies; public health and policy; and economics. Additionally, proposals that address the needs of minority, low-income, rural, and other underrepresented and/or medically underserved populations may be submitted from any eligible institutional source. Proposals are encouraged from investigators working at Historically Black Colleges and Universities/Minority Institutions (HBCU/MI). The intent of New Investigator Awards is to help investigators at the early stages of their careers to become established NF researchers. Although New Investigator Award proposals do not require preliminary data, they should be based on a sound scientific rationale established through a critical review and analysis of the literature and/or logical reasoning.
Funding for New Investigator Awards can be requested for an average of $150,000 per year in direct costs for a maximum of $450,000 over a 3-year performance period, plus indirect costs as appropriate. Projects requiring lower levels of funding also may be submitted. These funds can cover salary, expenses including research supplies, and travel to scientific/technical meetings. The amount for this travel may not exceed $1,800 per year. Institutional support and commitment must be evident to foster the applicants research career, such as the provision of access to adequate laboratory facilities and equipment. The nature of this Program does not allow for renewal of grants or supplementation of existing grants. Approximately $2M is available for this award mechanism. Depending on the number and quality of the applications, it is anticipated that approximately two to three proposals will be funded.
Electronic submission is required. Proposals must be approved on the CDMRP eReceipt system by the Contract Representative at the applicants institutions Sponsored Programs Office (or equivalent) by the deadline. If your proposal is either incomplete or not approved electronically before the deadline, it will not be considered for review. No paper copy submissions will be accepted. The CDMRP uses a two-tier review process for proposals: scientific peer review, followed by programmatic review. Details of both tiers of review can be found in the Full Text of Program Announcement.
Estimated timelines for the FY05 New Investigator Awards are as follows: Full Proposal Submission Deadline: February 22, 2005, 5:00 p.m. Eastern Time; Peer Review: April, 2005; Programmatic Review: July, 2005; Award Start Date: Between September, 2005 and January, 2006.
For additional information or questions, please contact: Patricia A. Evans, Contracting/Grants Office, U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, phone: (301) 619-7354, Fax: (301) 619-6662, email: email@example.com
Who can apply:
Eligible functional categories:
Military Medical Research and Development
FY05 Neurofibromatosis Research Program (NFRP) Announcements
If you have problems accessing the full announcement, please contact:
US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014